Skip to main content
Year archive

SAMSUNG BIOLOGICS CO.,LTD. — 2018 filings

All 20 regulatory filings released by SAMSUNG BIOLOGICS CO.,LTD. (207940) in 2018, sourced directly from the official regulator.

20 Filings
2018 Period
2018 filings (20)
Filing Released Lang
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2018-12-31 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2018-12-31 Korean
기타경영사항(자율공시)
Regulatory Filings
2018-12-10 Korean
기타시장안내(유가증권시장 기업심사위원회 심의결과 및 상장유지 결정 안내)
Regulatory Filings
2018-12-10 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Audit Report / Information Q2 2018
2018-11-30 Korean
기타시장안내(기업심사위원회 심의대상 결정)
Regulatory Filings
2018-11-30 Korean
투자판단관련주요경영사항
Legal Proceedings Report
2018-11-28 Korean
최대주주등소유주식변동신고서
Director's Dealing
2018-11-26 Korean
조회공시요구(풍문또는보도)
Regulatory Filings
2018-11-14 Korean
매매거래정지및정지해제(풍문등조회공시)
Regulatory Filings
2018-11-14 Korean
회계처리기준위반에따른검찰고발등조치
Legal Proceedings Report
2018-11-14 Korean
기타시장안내(상장적격성 실질심사 사유 발생 안내)
Regulatory Filings
2018-11-14 Korean
분기보고서 (2018.09)
Interim / Quarterly Report 9M 2018
2018-11-13 Korean
합병등종료보고서(자산양수도)
M&A Activity
2018-11-07 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2018-10-29 Korean
영업(잠정)실적(공정공시)
Earnings Release Q3 2018
2018-10-23 Korean
특수관계인과의예ㆍ적금거래
Capital/Financing Update
2018-10-23 Korean
약관에의한금융거래시계열금융회사의거래상대방의공시
Regulatory Filings
2018-10-23 Korean
결산실적공시예고(안내공시)
Report Publication Announcement
2018-10-17 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)
Regulatory Filings
2018-10-11 Korean